Avoid The Bridge To Nowhere In Your Startup’s Funding Plan

October 7, 2015

This XSeed blog was written by Venture Partner, Jeff Thermond, and originally appeared on Forbes.

I have seen several recent startup pitches covering different markets, having different technologies, and built with teams of differing calibers, all of which shared one unfortunate trait: The founders’ funding plans looked a lot like a Bridge to Nowhere. […]

Read More

Founders: Steer Clear Of This Dangerous Mindset

September 7, 2015

This XSeed blog was written by Venture Partner, Jeff Thermond, and originally appeared on VentureBeat.

When I ask friends with pilot’s licenses what the hardest thing was about learning to fly, they always say, “learning how to get out of a midair stall.” The hard thing about it, they tell me, is how counterintuitive the […]

Read More

Setting Sales Quotas Is Like Running A 10K Race

August 28, 2015

This XSeed blog was written by Venture Partner, Jeff Thermond, and originally appeared on TechCrunch.

If you’ve ever run a 10K road race, you know that race organizers spend a lot of effort to have volunteers at every milepost telling runners what their time is. If you’re like me, you’ve probably sped up at each […]

Read More

GeneWEAVE Acquired By Roche

August 14, 2015

One of our goals at XSeed is to invest in entrepreneurs who pursue risky, paradigm changing ideas to solve big problems that seem intractable using established approaches. Rapid, cost-effective diagnosis and data-guided treatment of antibiotic resistant diseases is one such problem – causing about 25,000 deaths and over 2 million illnesses a year in the U.S. alone, with new, ever more resistant bacterial strains evolving […]

Read More

SUBSCRIBE TO BLOG